{
    "code": "01013719",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01013719",
    "time": "2019-07-05 03:15:04",
    "許可證字號": "衛署藥製字第013719號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/05\/25",
    "發證日期": "66\/11\/03",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00101371907",
    "中文品名": "&quot;人生&quot;利博舒糖衣錠",
    "英文品名": "LIBUSE S.C. TABLETS &quot;JEN SHENG&quot;",
    "適應症": "胃與十二指腸潰瘍、胃十二指腸炎、腸胃蠕動亢進、神經性消化不良、膽道運動失調、腸痙攣、結腸炎、尿道痙攣及運動困難",
    "劑型": "119糖衣錠",
    "包裝": "瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "CLIDINIUM BROMIDE, CHLORDIAZEPOXIDE HCL",
    "主製造廠": {
        "申請商名稱": "0201709200  人生製藥股份有限公司",
        "申請商地址": "台中市西屯區工業區五路３號",
        "主製造廠": "",
        "製造廠名稱": "0201709300  人生製藥股份有限公司"
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208001610",
            "成分名稱": "CLIDINIUM BROMIDE",
            "含量描述": "2.5",
            "含量": "2.5000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2824200210",
            "成分名稱": "CHLORDIAZEPOXIDE HCL",
            "含量描述": "5",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "010137190001.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01013719&Seq=001&Type=9"
        }
    ]
}